Clinical Trial Update: Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer [NA]

View source ↗

Summary

This clinical trial update notes that the NCT01613521 study on tumor perfusion and hypoxia biomarkers in cervical cancer has been terminated; the trial explored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cervical Cancer | NA | Status: TERMINATED